India, June 11 -- Varun Grover has made a shocking revelation, and it is with regards to pay gap between writers and artists. Grover, known for his works like Masaan and Superboys of Malegaon, had bee... Read More
India, June 11 -- Bengaluru's real estate market has delivered strong returns in recent years, with investors reaping significant gains. But with emerging signs of a slowdown, many are now wondering i... Read More
India, June 11 -- Bengaluru's real estate market has delivered strong returns in recent years, with investors reaping significant gains. But with emerging signs of a slowdown, many are now wondering i... Read More
Dhaka, June 11 -- Veteran actor Amitabh Bachchan, known for his active presence on social media, continues to connect with fans by sharing thoughts on life, cinema, and more. Affectionately referring ... Read More
U.S., June 11 -- ClinicalTrials.gov registry received information related to the study (NCT07012577) titled 'Observational Study on AI Accuracy in Diagnosing and Treating Failed or Painful Hip Arthrop... Read More
U.S., June 11 -- ClinicalTrials.gov registry received information related to the study (NCT07013877) titled 'Audiovisual Distraction in Intensive Care' on June 02. Brief Summary: Resuscitation patien... Read More
U.S., June 11 -- ClinicalTrials.gov registry received information related to the study (NCT07013760) titled 'Characterize and Assess Clinical Outcomes of Patients Receiving Tezepelumab After Marketing... Read More
U.S., June 11 -- ClinicalTrials.gov registry received information related to the study (NCT07013591) titled 'Nicotinamide Mmononucleotide in Patients Undergoing CABG Surgery' on May 09. Brief Summary... Read More
U.S., June 11 -- ClinicalTrials.gov registry received information related to the study (NCT07013162) titled 'Efficacy of Laser Therapy for Periodontitis' on May 24. Brief Summary: The aim of this stu... Read More
U.S., June 11 -- ClinicalTrials.gov registry received information related to the study (NCT07012980) titled 'Glofitamab, Polatuzumab Vedotin and Zanubrutinib in First-line Elderly DLBCL' on May 24. B... Read More